Rituximab-treated rheumatic patients: B cells predict seroconversion after COVID-19 boost or revaccination in initial vaccine non-responders
Christian Gytz Ammitzbøll(Aarhus University), Anne Troldborg(Aarhus University), Jens Magnus Bernth Jensen(Aarhus University Hospital), Susan Mikkelsen(Aarhus University Hospital), Signe Risbøl Vils(Aarhus University), Marie‐Louise From Hermansen(Aarhus University Hospital), Mads Lamm Larsen(Aarhus University), Anders Dahl Johannsen(Aarhus University Hospital), Christian Erikstrup(Aarhus University Hospital), Marianne Kragh Thomsen(Aarhus University), J.B. Andersen(Aarhus University Hospital), Fruzsina Szabados, Clara Elbæk Mistegaard(Aarhus University), Ellen‐Margrethe Hauge(Aarhus University Hospital)
Cited by 16
Related Papers
Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers
|Journal of Bone and Mineral Research|2001|384
Large-scale study of Toxoplasma and Cytomegalovirus shows an association between infection and serious psychiatric disorders
|Brain Behavior and Immunity|2019|171
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis
|Journal of Clinical Investigation|2022|70
Platelet characteristics in patients with essential thrombocytosis
|Cytometry Part B Clinical Cytometry|2018|46